Berks Diabetes Management

Nurse Practitioner in Wyomissing, Pennsylvania — the CMS registry also lists obesity medicine among its taxonomies.

Practice Details

Address
1030 Reed Ave
Wyomissing, PA 19610
Geocoded location: 40.3382, -75.9624
Taxonomy
Nurse Practitioner, Adult Health
NPPES Enumeration
Listed with NPPES since 2015
Registered Contact
RALPH CINCINNATI, NURSE PRACTITIONER
NPPES Record Updated
September 2015

Specialty taxonomies on file (2)

  • Endocrinology
    Internal Medicine, Endocrinology, Diabetes & Metabolism
  • Nurse Practitioner
    Nurse Practitioner, Adult Health
    Primary

All specialty taxonomies this NPI reports in the CMS National Provider registry. A taxonomy on file reflects a self-reported designation, not confirmation of current services.

About This Practice

Berks Diabetes Management is enumerated with NPPES as a Nurse Practitioner clinic; the CMS registry also lists obesity medicine among its taxonomies. The registry does not break out which specialties are staffed at this location — call ahead to confirm obesity-medicine or GLP-1 services are actively offered here.

This practice address has 2 individual clinicians enumerated with NPPES under the same location.

Locally, this is 1 of 7 Nurse Practitioner, Adult Health practices in Wyomissing carrying this exact taxonomy in our directory.

What to expect at a Nurse Practitioner visit

Nurse practitioners provide primary and specialty care and, depending on state scope-of-practice rules, prescribe independently or in collaboration with a physician. A GLP-1-related visit often includes:

  • A health and medication history and goal-setting conversation.
  • Screening labs where indicated before starting therapy.
  • A discussion of GLP-1 options for diabetes or weight management.
  • Follow-up to monitor response and adjust dose.

This is general guidance for nurse practitioner practices, not a description of Berks Diabetes Management's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 610-373-7743.

GLP-1 access in Wyomissing, Pennsylvania

Adult obesity rate
33.4%
#20 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$209/mo
Typical Pennsylvania telehealth cash price
Medicaid GLP-1 coverage
Diabetes + obesity (with prior auth)
Pennsylvania Medicaid, obesity indication

About 33.4% of Pennsylvania adults have obesity (BMI 30+), ranking the state #20 of 50 (CDC BRFSS). Our directory currently lists 16 GLP-1-relevant clinics in Wyomissing. If a cash-pay route makes more sense, compounded semaglutide through Pennsylvania telehealth averages about $209/mo — well below brand-name Wegovy or Zepbound.

Explore more Pennsylvania options on the best Pennsylvania GLP-1 providers page, browse every Wyomissing listing in the Wyomissing clinic directory, or read the Pennsylvania Medicaid GLP-1 coverage & prior-authorization guide.

Related Practices in Wyomissing

Other Wyomissing listings in the same directory tier:

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to Pennsylvania addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured Pennsylvania telehealth partners:

Featured Partners · Wyomissing

Featured GLP-1 providers serving Wyomissing

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick

    Compounded from

    $249.99/mo

    Save $1,099.01/mo vs Wegovy
    Get started →
  2. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 8.2

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  6. Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →

See more Wyomissing options on the Wyomissing clinic directory, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Wyomissing obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Berks Diabetes Management's specialty taxonomy but not the specific medications it prescribes or its current service menu. Berks Diabetes Management is listed under Nurse Practitioner, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 610-373-7743 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Berks Diabetes Management's primary specialty on file is Nurse Practitioner, and the registry also lists obesity medicine among its taxonomies. The registry records the taxonomy on file, not the individual clinicians staffed at this location.
Berks Diabetes Management is located at 1030 Reed Ave, Wyomissing, PA 19610. The phone number listed in the registry is 610-373-7743. Its full record is public in the CMS National Provider registry under NPI 1619345436.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Berks Diabetes Management is currently accepting new patients. Call the practice at 610-373-7743 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.